Protection from Previous Natural Infection Compared with mRNA Vaccination Against SARS-CoV-2 Infection and Severe COVID-19 in Qatar: A Retrospective Cohort Study
The Lancet Microbe This article compares the anti-COVID-19 protection conferred by natural infection versus that from the BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna) vaccines in Qatar. Journal Article
Read More